Skip to main content
OpenTrials
Completed

NCT Number: NCT00315471

Determining Disease Activity Biomarkers in Individuals With Takayasu's Arteritis

Takayasu's arteritis is a rare disorder that causes swelling and damage to the large arteries in the body, such as the aorta. In order to ensure proper treatment, measuring disease activity is critical. The purpose of this study is to establish new biological markers (biomarkers) to assess the severity of disease in people with Takayasu's arteritis.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

St. Joseph's Healthcare, Hamilton, Ontario, Canada

Loading trial locations.

About this study

Takayasu's arteritis is a chronic inflammatory condition that affects the aorta, the largest blood vessel in the body, and its branches. Inflammation causes segments of the vessels to become narrowed, blocked, or even stretched, possibly resulting in aneurysms. The disease is very rare but most commonly occurs in young Asian women. Symptoms may include arm pain with use, decreased or absent pulses, lightheadedness or dizziness, headaches, and visual disturbances. Many individuals with Takayasu' arteritis, however, have no apparent symptoms despite disease activity. Additionally, current tests used to measure vessel inflammation are considered unreliable and inconsistent. It is therefore very difficult to determine the extent of disease activity in a person with Takayasu's arteritis. This study will use novel scientific methods to establish new biomarkers that can be used to monitor disease activity in individuals with Takayasu's arteritis. These biomarkers may be used to help direct clinical care and assist in future drug development.

Study visits will occur monthly for the first year, then every 3 months thereafter for the remainder of the study. Blood and urine collection will occur at every visit. A physical examination, disease assessment, and review of medications will occur every 3 months; participants may also be asked to complete various questionnaires. Diagnostic testing, which may include chest radiograph, echocardiogram, magnetic resonance imaging, or angiography, will occur every 6 months. Tobacco, alcohol, and drug use will be assessed on a yearly basis. Participants may have additional study visits if a disease flare or disease-related complications occur during the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Evidence of arteriogram abnormalities compatible with Takayasu's arteritis (includes conventional dye angiography, magnetic resonance angiography, or computed tomography angiography)
  • Evidence of one of the following criteria:
  • Age at disease onset of 50 years or younger
  • Claudication of the arms or legs
  • Decreased brachial artery pulse (one or both arteries)
  • Blood pressure difference between the arms of at least 10 mm Hg
  • Bruit over the subclavian arteries or aorta
  • Parental consent for children under the age of 18

Exclusion criteria

  • Arteriographic lesions that could be entirely due to atherosclerosis
  • Fibromuscular dysplasia
  • Cogan's syndrome
  • Behcet's disease
  • Sarcoidosis
  • Kawasaki disease
  • Giant cell arteritis (large vessel vasculitis and at least 50 years old)
  • Syphilis or other infectious forms of large vessel vasculitis

Treatment and study plan

Primary outcomes

  1. Discover biomarkers in Takayasu's arteritis capable of measuring disease activity and response to treatment.

    Time frame: Study completion

Secondary outcomes

  1. Measure the predictive value of biomarkers for clinical outcome in Takayasu's arteritis.

    Time frame: Study completion.

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
  • Office of Rare Diseases (ORD)
  • Rare Diseases Clinical Research Network

Registry information

Official study title

VCRC Longitudinal Protocol for Takayasu's Arteritis

Important dates

Study start
2006
Primary completion
2019
Study completion
2019
First posted
Apr 18, 2006
Registry last updated
Jul 12, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.